Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesUsing Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evidence-based Complementary and Alternative Medicine , 10/05/09
Alleva LM et al. – The example given here of an ancient Chinese medicine formula used to treat influenza containing nine (out of 11) herbs with anti–inflammatory properties provides compelling evidence that the way forward for the treatment of influenza in a pandemic should be immunomodulation. The host response is targeted, rather than the virus itself. The authors' observation that treatment of influenza virus–infected mice with a pharmaceutical used in humans, the lipid–lowering and immunomodulatory PPAR alpha agonist gemfibrozil, resulted in significantly decreased influenza–induced mortality, further shows that targeting the host response is a valid possibility. The natural immunomodulatory agent biochanin A from Red Clover, which is both a PPAR alpha and PPAR gamma agonist, could have similar effects to gemfibrozil on the course of influenza disease in vivo. Chinese herbs such as A. sinensis and S. miltiorrhiza which independently reduce secretion of the novel inflammatory cytokine HMGB1, and glycyrrhizin from liquorice root, which binds to HMGB1 and inactivates its activity, provide another avenue for investigation, as does the establishment of the role of HMGB1 in severe influenza.
Lisa Alleva, 10/05/09
| Immunomodulatory treatments could be harnessed to treat severe influenza. We propose that complementary and alternative medicine, as well as conventional medicine, should be explored for therapies, and that special attention should be payed to those therapies that specifically tone-down the pro-inflammatory response. |
Related Articles
H1N1 Vaccine Production, Availability Increasing Slowly
American Family Physician, 11/02/09
Relevance Score: 88%
Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 84%
The first Pandemic of the 21st Century: A Review of the 2009 Pandemic Variant Influenza A (H1N1) Virus
Postgraduate Medicine, 10/02/09
Relevance Score: 84%
Bacterial Coinfections in Lung Tissue Specimens From Fatal Cases of 2009 Pandemic Influenza A (H1N1)--United States, May-August 2009
JAMA, 11/04/09
Relevance Score: 83%
Detection and subtyping of influenza A virus based on a short oligonucleotide microarray
Diagnostic Microbiology and Infectious Disease, 10/20/09
Relevance Score: 83%
Today in Complementary Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Successful Treatment of Paraquat Poisoning by Xuebijing, an Injection Concocted from Multiple Chinese Medicinal Herbs: A Case Report
Journal of Alternative and Complementary Medicine, 12/17/09
Localization of Acupuncture Points BL25 and BL26 Using Computed Tomography
Journal of Alternative and Complementary Medicine, 12/17/09
A Nonsurgical Approach to the Management of Patients With Lumbar Radiculopathy Secondary to Herniated Disk: A Prospective Observational Cohort Study With Follow-Up
Journal of Manipulative and Physiological Therapeutics, 12/17/09
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?
Journal of General Internal Medicine, 12/17/09
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
Postoperative spondylodiscitis due to Kytococcus schroeteri in a diabetic woman
Journal of Medical Microbiology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor